SKOOT is a platform that connects friends who need lifts or errands, with friends who can help. The app auto-calculates fares for lifts taken and splits the costs. It also permits users to organise, request and arrange errands or simple favours from friends for free or a £5 tip. SKOOT claims to be the only carbon negative green navigation app for drivers. The company argues that it has also taken up the '1 Million Tree Challenge' and plants a tree for every journey on the platform. SKOOT is live on the Apple App Store and Google Playstore, with more than 18,000 users. It aims to become a contender in the ride-hailing industry that is worth $85.8 billion. SKOOT states it has raised £3.1 million from investors, won £75,000 from Innovate UK, and completed over 1,200 tasks to date using its 'Errands' feature launched during the COVID-19 pandemic. SKOOT states they will use the investment to extend its product, create more revenue streams and increase user activation across the EU, USA, Australia and Canada by early 2022.
days to go:
Expired
investment:
£409,913
8dates is a dating recommendation engine and marketplace for new couples. The company's app uses machine learning to know what couples want when they first meet and shows them upcoming events by partner affiliates that they can engage in as per their interest. 8dates affiliate partners include OpenTable and Eventbrite. The company has also been granted the Facebook Dating License for advertising. It will use the investment to localise its offerings across key markets in the UK and Europe and grow its affiliate partnership program by adding more events. They will also develop the Android version of its application, acquire patents, copyrights, and IP expansion for its trademarks, app development, and UI/UX updates, and boost marketing and customer acquisition via Facebook, TikTok, Instagram, Spotify, and Pandora.
days to go:
Expired
investment:
£357,242
Active Needle Technology offers an award-winning "needle actuating device" which has high value medical and consumer applications. The company's patent-pending proprietary ultrasonic technology enhances visibility for medical needles in applications such as biopsy, in regional and joint anaesthesia and others. The company aims to commercialise its technology into a $4+ billion special purpose needle market. After identifying obvious commercial advantages in the tattoo market, Active Needle plans to use its ultrasonic needle technology to develop a low-pain tattooing system. Moreover, the company has won an Innovate UK grant to develop and test the tattoo device. With the proceeds, the company will complete CE marking for its initial biopsy device, for development of anaesthesia and tattooing products.
days to go:
Expired
investment:
£194,100
The Fertility Circle (TFC) aspires to become the go-to channel for one in six couples that are struggling to conceive. It aims to help them via its app that consists of four core features namely, community guidance, expert help, knowledge sources, and holistic support channels. The company aims to become a contender in the fertility market that is projected to hit $41 billion by 2026. TFC asserts that it is supported by notable entities like Virgin Startup, FemTech Lab, and 'M' accelerators. TFC has featured in media entities like Grazia, Thomson Reuters, and Thrive Global and was included in Apple's ‘Hot Right Now' list being ranked second for 'Fertility Support' in the App Store. The company has witnessed a 40% Month-on-Month (MoM) user growth, over 6,000+ app downloads in 6 months, and a social community presence of 5,000 followers to date. TFC will use the investment to pilot with six leading fertility clinics to offer the application to their patients.
days to go:
Expired
investment:
£391,372
TIME-TO-FIND is a reverse marketplace for luxury Swiss watches that helps customers locate the watch they want from the company's network of brand authorised stockists. The company's complimentary service allows customers to communicate with and compare authorised retailers without any commitment with a simple sign-up process. When the customer is ready to transact, they can choose TIME-TO-FIND's bespoke concierge service to hand-deliver their desired watch to their doorstep. Customers can also opt for the secure courier service from their chosen authorised stockist to their nominated delivery address. TIME-TO-FIND garnered £80,000 worth of sales at retail value in its pilot period from August to December 2019 with zero returns. TIME-TO-FIND will use the investment to create marketing and PR campaigns to boost sales, increase site visits to 500,000 within 2021-2022, improve its website's user experience, and hire key personnel.
days to go:
Expired
investment:
£281,731
Uhive is a cryptocurrency-powered social network that aims to foster peer-to-peer (P2P) transactions, interest-based advertising, and the sale of in-app digital assets to maintain user privacy on its portal. The company argues that current social networks flood users' feeds with hidden agendas auctioning off their data to the highest bidder. Uhive intends to change this. It asserts that its content-discovery model allows users to choose and fine-tune the content they see by selecting 26 different interests. Content creators can use Uhive's paywall feature to earn, rewarding quality posts with cryptocurrency payments. The company's app consists of an advanced AI and recommendation engine, crypto wallet, and media streaming, to name a few. Uhive has onboarded 182,000 users and witnessed 5 million posts created by users on its platform. It will use 23% of the investment for operations, 55% for product development, 21% for marketing, and 1% for legal costs.
days to go:
Expired
investment:
£815,530
Comino is an international start-up specialising in the design and production of liquid-cooled PCs and servers. It claims that its products consume up to 40% less electricity than equivalent air-cooling computers. The company currently operates in AI, Forensic, Gaming, and Video Rendering, with aspirations to enter other domains in the coming years. Comino has sold 2,000 work stations to professional businesses, accruing sales north of 9 million EUR since its launch in 2017. Its products have been accredited by global hardware giants like AMD and ASUS. The company will use 70% of proceeds for manufacturing its devices, 10% towards marketing and promotional materials, and 20% to compensate its teams.
days to go:
Expired
investment:
£949,608
Common Objective is a global B2B sourcing and information platform that rewards sustainable business through higher search rankings. The company aims at disrupting the $2trillion fashion industry as it has already used by 23k+ fashion professionals who work at leading brands and 1000’s of SME’s, from over 150 countries. The company’s online platform uses personalisation and matching technology to connect buyers with suppliers and provides them with targeted content and tools supporting best practice. The site is used by individuals and teams who work at world-leading brands backed by industry leaders including Roland Mouret, PDS Multinational, and Plexus Cotton.
days to go:
Expired
investment:
£462,260
Evaclite manufactures dynamic exit signs designed to make buildings safer and save lives. The company argues that its products are 77% more visible than conventional exit signs and reduces congestion at exits by 36%. The company received the 2018 FIREX - Fire Innovation of the Year Award. It also won the Safety and Health Excellence (SHE) Award in 2019 and 2020. Evaclite counts companies like Apple, CBRE, BBC, Melia, and MetroBank amongst its clients. The company has inquiries from over a dozen countries globally with a 12-month sales opportunity pipeline of over £1.5 million. It will use 60% of the investment to build its sales team, 28% to boost its inbound marketing campaign, 7% to develop additional intellectual property, and 5% towards overhead and general costs.
days to go:
Expired
investment:
£148,736
Luas Diagnostics (LD) aims to develop and market easy-to-use, rapid and accurate diagnostics tests with the aim of deploying these tests in remote settings away from centralised testing laboratories. The company has signed an exclusive distribution agreement with Chembio Diagnostics Systems (CDS) in the USA to market its Covid-19 antibody and antigen tests in the UK and Ireland. It has also signed a Memorandum of Understanding (MoU) with the University of Birmingham to develop saliva-based, rapid Covid-19 tests. LD is also working on coming up with a therapeutic drug monitoring system based on the same technology used worldwide to test people with diabetes for glucose levels in the blood. The company is developing the system so that it can be used at home, in pharmacies or GP surgery. The first product will test for Theophylline which is used to treat Chronic Obstructive Pulmonary Disease (COPD). LD will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£326,190
